Scott Rocklage became a managing partner of 5AM Ventures in 2004 and brings with him over 30 years of experience in the healthcare management field.
Under his leadership, the drugs Cubicin, Omniscan, and Teslascan were approved by the FDA, and many other drug candidates were entered into clinical trials, as well, under his direction. The idea for 5AM, a life science-based venture capital firm, came from the fact that it works companies in their earliest stages. Learn more about Scott Rocklage: http://5amventures.com/team/scott-m-rocklage-phd/
5AM is early for most people, and this is where the name came from. While Scott doesn’t have what he refers to as a “typical day,” he does find himself learning more about life science on many days as well as getting board meetings ready. Every day, Scott works with physicians, scientists, and other entrepreneurs in the life science industry who are looking to get started the right way.
Some Of The Reasons For Scott’s Success
Scott Rocklage focuses a lot of his energy on managing his time and is very good at staying organized and on top of his calendar. He believes that more companies should be focusing on the people that help them to succeed and that selecting the right team is part of the crucial foundation of any new startup. Read more: Scott Racklage | Bloomberg
He encourages other people to work for themselves and believes that anybody who wishes to succeed should not fear taking measured risks that can improve the state of their life or their business. One of these measured risks is going into business for themselves rather than working for someone else.
Last, but not least, Scott Rocklage has learned, through his own experience, that it is vital for a business to keep its focus on what it does best. He knows that when businesses stray off into other areas that they don’t have expertise in, this is when they can fail.
Some Past History
Before coming to 5AM Ventures, Scott Rocklage was the CEO and Chairman for Cubist Pharmaceuticals, and he also was the President of Nycomed Salutar.
Scott earned his Bachelor’s of Science in chemistry while studying at the University of California, Berkley and a Ph.D. while attending the Massachusetts Institute of Technology.